✦ LIBER ✦

Interferon and ribavirin therapy does not select for resistance mutations in hepatitis C virus polymerase

✍ Scribed by C. L. Ward; A. Dev; S. Rigby; W. T. Symonds; K. Patel; A. Zekry; J.-M. Pawlotsky; J. G. McHutchison

Book ID: 108886135
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 68 KB
Volume: 15
Category: Article
ISSN: 1352-0504
DOI: 10.1111/j.1365-2893.2008.00980.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Changes in haemoglobin during interferon

Changes in haemoglobin during interferon alpha-2b plus ribavirin combination therapy for chronic hepatitis C virus infection

✍ M. S. Sulkowski; R. Wasserman; L. Brooks; L. Ball; R. Gish 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

Prediction of sustained virological resp

Prediction of sustained virological response in liver transplant recipients with recurrent hepatitis C virus following combination pegylated interferon alfa-2b and ribavirin therapy using tissue hepatitis C virus reverse transcriptase polymerase chain reaction testing

✍ Guy W. Neff; Christopher B. O'Brien; Robert Cirocco; Marzia Montalbano; Maria de 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 2 views

The optimal duration of therapy for pegylated interferon combined with ribavirin in recurrent Hepatitis C virus (HCV) following liver transplantation is not known. We wanted to determine if testing for HCV in liver tissue by reverse transcriptase polymerase chain reaction (RT-PCR) was superior in pr

Mutations in the core and NS5A region of

Mutations in the core and NS5A region of hepatitis C virus genotype 1b and correlation with response to pegylated-interferon-alpha 2b and ribavirin combination therapy

✍ K. Hayashi; Y. Katano; M. Ishigami; A. Itoh; Y. Hirooka; I. Nakano; F. Urano; K. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

Mutations in NS5A region of hepatitis C

Mutations in NS5A region of hepatitis C virus genome correlate with presence of NS5A antibodies and response to interferon therapy for most common european hepatitis C virus genotypes

✍ Lionel Frangeul; Pascale Cresta; Michele Perrin; Françoise Lunel; Pierre Opolon; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 2 views

A part of the hepatitis C virus (HCV) nonstructural protein 5A (NS5A) amino acid sequence, designated as an interferon (IFN)-sensitive determining region (ISDR), has been shown to be correlated with a response to IFN in Japanese patients. We have shown previously that the presence of NS5A antibodies

Correlation between mutations in the cor

Correlation between mutations in the core and NS5A genes of hepatitis C virus genotypes 1a, 1b, 3a, 3b, 6f and the response to pegylated interferon and ribavirin combination therapy

✍ K. Kumthip; C. Pantip; P. Chusri; S. Thongsawat; A. O’Brien; K. E. Nelson; N. Ma 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Chemiluminescence enzyme immunoassay for

Chemiluminescence enzyme immunoassay for monitoring hepatitis C virus core protein during interferon-α2b and ribavirin therapy in patients with genotype 1 and high viral loads

✍ Masaru Enomoto; Shuhei Nishiguchi; Akihiro Tamori; Modoka Kohmoto; Daiki Habu; H 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 1 views

## Abstract This study evaluated an updated chemiluminescence enzyme immunoassay (CLEIA) for hepatitis C virus (HCV) core protein for monitoring viral kinetics during treatment with interferon (IFN)‐α and ribavirin. Using the CLEIA, serum levels of HCV core protein were measured in 17 patients with